(S)-tert-Butyl 3-((4-chloro-5-methylpyrimidin-2-yl)oxy)pyrrolidine-1-carboxylate

Catalog No. :
ACPDJI532
CAS No. :
1264035-24-6
Molecular Formula :
C14H20ClN3O3
Molecular Weight :
313.79

IUPAC Name:tert-butyl (S)-3-((4-chloro-5-methylpyrimidin-2-yl)oxy)pyrrolidine-1-carboxylate

(S)-tert-Butyl 3-((4-chloro-5-methylpyrimidin-2-yl)oxy)pyrrolidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$595.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-tert-Butyl 3-((4-chloro-5-methylpyrimidin-2-yl)oxy)pyrrolidine-1-carboxylate
IUPAC Nametert-butyl (S)-3-((4-chloro-5-methylpyrimidin-2-yl)oxy)pyrrolidine-1-carboxylate
MDL No.MFCD18380142
Molecular FormulaC14H20ClN3O3
Molecular Weight313.79
SMILESO=C(N1C[C@@H](OC2=NC=C(C)C(Cl)=N2)CC1)OC(C)(C)C
InChI KeyWWINDAUYBILPGN-JTQLQIEISA-N
Synonym(S)-3-(4-Chloro-5-methyl-pyrimidin-2-yloxy)-pyrrolidine-1-carboxylic acid tert-butyl ester
CAS No.1264035-24-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPDJI532 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPRSC401 route compound structure diagram
    ACPRSC401101469-92-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPDJI532 route product structure diagram
    ACPDJI5321264035-24-6
Inquiry

2. ACPDJI532 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPRSC401 route compound structure diagram
    ACPRSC401101469-92-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPDJI532 route product structure diagram
    ACPDJI5321264035-24-6
Inquiry

Comments (0)